GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Resources (Shanghai) Co Ltd (SZSE:301230) » Definitions » Accounts Payable & Accrued Expense

Pharma Resources (Shanghai) Co (SZSE:301230) Accounts Payable & Accrued Expense : ¥79.1 Mil (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Pharma Resources (Shanghai) Co Accounts Payable & Accrued Expense?

Pharma Resources (Shanghai) Co's quarterly accounts payable & accrued expense declined from Sep. 2024 (¥109.7 Mil) to Dec. 2024 (¥88.7 Mil) and declined from Dec. 2024 (¥88.7 Mil) to Mar. 2025 (¥79.1 Mil).

Pharma Resources (Shanghai) Co's annual accounts payable & accrued expense increased from Dec. 2022 (¥77.1 Mil) to Dec. 2023 (¥151.5 Mil) but then declined from Dec. 2023 (¥151.5 Mil) to Dec. 2024 (¥88.7 Mil).

Pharma Resources (Shanghai) Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Pharma Resources (Shanghai) Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Resources (Shanghai) Co Accounts Payable & Accrued Expense Chart

Pharma Resources (Shanghai) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 58.38 90.03 77.13 151.53 88.67

Pharma Resources (Shanghai) Co Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 128.85 136.59 109.69 88.67 79.09

Pharma Resources (Shanghai) Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Pharma Resources (Shanghai) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Resources (Shanghai) Co Ltd (SZSE:301230) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
SHSE:688687 BJSE:430047 SZSE:003020 SZSE:301333 SHSE:688089 SHSE:688253 SHSE:603718 SHSE:688767 SHSE:688293 SZSE:300318 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 315, Qingda Road, Building 23, Pudong New Area, Shanghai, CHN, 201201
Website
http://www.pharmaresources.cn
Pharma Resources (Shanghai) Co Ltd is engaged in the drug discovery, research and development of pharmaceutical processes, and commercial production of API intermediates.

Pharma Resources (Shanghai) Co Headlines

No Headlines